We understand that people with cancer are worried about coronavirus. Here is the latest guidance. We will update it regularly.

My Macmillan

Publications directory

Need to talk? Call us free*
0800 808 00 00 Monday to Friday, 9am-8pm

The web Directory of Information Materials for People Affected by Cancer is regularly updated and currently has details of over 1,900 booklets, leaflets, books and audiovisual materials for people affected by cancer. Most have been published in the last five years but we have included some older ones that are still useful.

Results: 1214

Cover image of 'Patient diary'

Patient diary (March 2019)

Myeloma UK

This diary has been designed to do just that; to give you a place to write down your thoughts, how you are feeling and any questions you may have. It will help you stay informed and keep track of important information related to your myeloma and its treatment. It may also help you and your doctor and nurse communicate more easily about your myeloma, your treatment and any questions or concerns that you may have. 

Cover image of 'Elotuzumab (Empliciti®)'

Elotuzumab (Empliciti®) (November 2019)

Myeloma UK

Elotuzumab is a new drug that is being investigated for the treatment of myeloma. This factsheet describes briefly what it is, how it works, how it is given, the possible benefits over existing drugs, the possible side-effects, its availability in the UK, and the future.

Cover image of 'Bortezomib (Velcade®)'

Bortezomib (Velcade®) (January 2019)

Myeloma UK

Bortezomib, also known as Velcade®, is a proteasome inhibitor drug used in the treatment of myeloma. This factsheet describes what it is, how it works, how it is given, and possible side-effects.

Cover image of 'Daratumumab (Darzalex®)'

Daratumumab (Darzalex®) (January 2019)

Myeloma UK

Daratumumab, also known as Darzalex®, is a monoclonal antibody drug used in the treatment of myeloma. This booklet describes what it is, how it works, how it is given, and the possible side-effects.

Cover image of 'Dexamethasone'

Dexamethasone (January 2019)

Myeloma UK

Dexamethasone is a steroid drug used in the treatment of myeloma. It belongs to a class of steroids called glucocorticoids. This factsheet describes what it is, how it works, how it is given, and possible side-effects.

Cover image of 'Melphalan'

Melphalan (January 2019)

Myeloma UK

Melphalan is a chemotherapy drug used in the treatment of myeloma. It belongs to a class of chemotherapy drugs called alkylating agents.This factsheet describes what it is, how it works, how it is given, and possible side-effects.

Cover image of 'Lenalidomide (Revlimid®)'

Lenalidomide (Revlimid®) (January 2019)

Myeloma UK

Lenalidomide, also known as Revlimid®, is an immunomodulatory drug (IMiD) used in the treatment of myeloma.This factsheet describes what it is, how it works, how it is given, and possible side-effects.

Cover image of 'Reolysin®'

Reolysin® (July 2019)

Myeloma UK

Reolysin, also known as pelareorep, is a type of oncolytic virus being investigated for the treatment of myeloma and various other cancers. This factsheet explains what reolysin is, how it works, and the current evidence to support its use in the treatment of myeloma. It also describes the known possible side-effects, and the availability of reolysin in the UK.

Cover image of 'Chemotherapy regimens for lymphoma'

Chemotherapy regimens for lymphoma (February 2019)

Lymphoma Action

This information sheet is about chemotherapy regimens (combinations of drugs) for lymphoma. It covers: What is a chemotherapy regimen?; Common chemotherapy regimens for lymphoma; Which chemotherapy regimen might I have?; Side effects of chemotherapy regimens. Includes a list of the most common chemotherapy regimens for lymphoma. 

Cover image of 'Thalidomide'

Thalidomide (January 2019)

Myeloma UK

This treatment guide has information about thalidomide, a drug used in the treatment of myeloma. It explains  what it is, how it works, and how it is given, and describes the possible side-effects.

Sorry, no publications found.
Need to talk? Call us free*
0800 808 00 00 Monday to Friday, 9am-8pm